The CATERPILLER protein monarch-1 is an antagonist of toll-like receptor-, tumor necrosis factor alpha-, and Mycobacterium tuberculosis-induced pro-inflammatory signals

J Biol Chem. 2005 Dec 2;280(48):39914-24. doi: 10.1074/jbc.M502820200. Epub 2005 Oct 3.

Abstract

The CATERPILLER (CLR, also NOD and NLR) proteins share structural similarities with the nucleotide binding domain (NBD)-leucine-rich repeat (LRR) superfamily of plant disease-resistance (R) proteins and are emerging as important immune regulators in animals. CLR proteins contain NBD-LRR motifs and are linked to a limited number of distinct N-terminal domains including transactivation, CARD (caspase activation and recruitment), and pyrin domains (PyD). The CLR gene, Monarch-1/Pypaf7, is expressed by resting primary myeloid/monocytic cells, and its expression in these cells is reduced by Toll-like receptor (TLR) agonists tumor necrosis factor (TNF) alpha and Mycobacterium tuberculosis. Monarch-1 reduces NFkappaB activation by TLR-signaling molecules MyD88, IRAK-1 (type I interleukin-1 receptor-associated protein kinase), and TRAF6 (TNF receptor (TNFR)-associated factor) as well as TNFR signaling molecules TRAF2 and RIP1 but not the downstream NFkappaB subunit p65. This indicates that Monarch-1 is a negative regulator of both TLR and TNFR pathways. Reducing Monarch-1 expression with small interference RNA in myeloid/monocytic cells caused a dramatic increase in NFkappaB activation and cytokine expression in response to TLR2/TLR4 agonists, TNFalpha, or M. tuberculosis infection, suggesting that Monarch-1 is a negative regulator of inflammation. Because Monarch-1 is the first CLR protein that interferes with both TLR2 and TLR4 activation, the mechanism of this interference is significant. We find that Monarch-1 associates with IRAK-1 but not MyD88, resulting in the blockage of IRAK-1 hyperphosphorylation. Mutants containing the NBD-LRR or PyD-NBD also blocked IRAK-1 activation. This is the first example of a CLR protein that antagonizes inflammatory responses initiated by TLR agonists via interference with IRAK-1 activation.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptor Proteins, Signal Transducing / metabolism
  • Amino Acid Motifs
  • Antigens, Differentiation / metabolism
  • Caspases / chemistry
  • Cell Line
  • Cytokines / metabolism
  • Cytoskeletal Proteins / chemistry
  • Enzyme-Linked Immunosorbent Assay
  • Genes, Reporter
  • Humans
  • Immunoprecipitation
  • Inflammation
  • Interleukin-1 Receptor-Associated Kinases
  • Intracellular Signaling Peptides and Proteins / metabolism
  • Intracellular Signaling Peptides and Proteins / physiology*
  • Luciferases / metabolism
  • Monocytes / metabolism
  • Mycobacterium tuberculosis / metabolism*
  • Myeloid Differentiation Factor 88
  • NF-kappa B / metabolism
  • Nuclear Pore Complex Proteins / metabolism
  • Phosphorylation
  • Plasmids / metabolism
  • Promoter Regions, Genetic
  • Protein Kinases / metabolism
  • Protein Structure, Tertiary
  • Pyrin
  • RNA / metabolism
  • RNA, Small Interfering / metabolism
  • RNA-Binding Proteins / metabolism
  • Receptors, Immunologic / metabolism
  • Retroviridae / genetics
  • Reverse Transcriptase Polymerase Chain Reaction
  • Signal Transduction
  • TNF Receptor-Associated Factor 2 / metabolism
  • TNF Receptor-Associated Factor 6 / metabolism
  • Toll-Like Receptors / metabolism*
  • Transcription Factor RelA / metabolism
  • Transcriptional Activation
  • Transfection
  • Tumor Necrosis Factor-alpha / metabolism*

Substances

  • AGFG1 protein, human
  • Adaptor Proteins, Signal Transducing
  • Antigens, Differentiation
  • Cytokines
  • Cytoskeletal Proteins
  • Intracellular Signaling Peptides and Proteins
  • MEFV protein, human
  • MYD88 protein, human
  • Myeloid Differentiation Factor 88
  • NF-kappa B
  • NLRP12 protein, human
  • Nuclear Pore Complex Proteins
  • Pyrin
  • RELA protein, human
  • RNA, Small Interfering
  • RNA-Binding Proteins
  • Receptors, Immunologic
  • TNF Receptor-Associated Factor 2
  • TNF Receptor-Associated Factor 6
  • Toll-Like Receptors
  • Transcription Factor RelA
  • Tumor Necrosis Factor-alpha
  • RNA
  • Luciferases
  • Protein Kinases
  • Interleukin-1 Receptor-Associated Kinases
  • Caspases